Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review.

Ume Habiba Radeyah Waseem Taha Gul Shaikh Summaiyya Waseem Syed Hassan Ahmed Muhammad Sohaib Asghar

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

Lemborexant is well integrated with the amelioration of sleep disturbances in insomniac patients, as shown by a decrease in eSOL and sWASO and a rise in sSE, sTST, quality of sleep, and morning alertness. Effects last 12 months after therapy.

Keyphrases

end stage renal disease
sleep quality
newly diagnosed
physical activity
chronic kidney disease
peritoneal dialysis
depressive symptoms
patient reported outcomes
patient reported